DelveInsight is a prominent provider of valuable research within biotech and pharmaceutical industries. It offers analytical reports in such Health Care sectors as gene therapy, medical oncologic therapy, Active Pharmaceutical Ingredient (API) manufacturing, stem cell medication, biosimilars, orphan drugs and others. The expertise includes:
- Company’s profile and licensing data;
- New technology studies;
- Biologic benchmarking;
- Treatment modality analysis;
- Competitive landscape;
- Product assessment; etc.
This knowledge is essential for Generic and Drug Development companies, which also receive drug sales estimation and product performance forecasts.
DelveInsight reconciles customers need for information and for innovative approaches in business development. Consequently, the obtained data is turned into strategic design, partner up opportunities, profit earning capacity of the business. DelveInsight analysts assist pharma enterprises in launching new products and marketing development of existing pharmaceutics.
Publications found:
6,889
Sort by:
Inclusion Body Myositis - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Inclusion Body Myositis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
India Healthcare Outlook Report, 2022
US$ 1,995.00
This report can be delivered to the clients within 24 Hours Healthcare is one of India’s major sector, both in terms of revenue and employment. The Indian healthcare sector is growing at a brisk pac...
January 2022
60 pages
Inflammatory breast cancer - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Inflammatory breast cancer - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dise...
January 2022
60 pages
Inflammatory Pain - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Inflammatory Pain - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, hist...
January 2022
60 pages
Inguinal Hernia - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Inguinal Hernia - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
Inherited Retinal Disease - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Inherited Retinal Disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Injection Site Irritation - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Injection Site Irritation - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Integrin alpha4beta1 antagonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “Integrin alpha4beta1 antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 5+ compa...
January 2022
60 pages
Interleukin 1 beta inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Interleukin 1 Beta Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 11+ companies and 12...
January 2022
60 pages
Interleukin 13 inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Interleukin-13 (IL-13) Inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 10+ companies an...
January 2022
60 pages
Interleukin 4 inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 hours DelveInsight’s, “Interleukin 4 inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 4+ companies and 4+ pipel...
January 2022
60 pages
Interleukin 6 inhibitors - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 3-4 Business Days DelveInsight’s, “Interleukin 6 inhibitors - Pipeline Insight, 2022” report provides comprehensive insights about 15+ companies an...
January 2022
60 pages
Interleukin 8 receptor antagonists - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 2-3 Business Days DelveInsight’s, “Interleukin 8 receptor antagonists - Pipeline Insight, 2022” report provides comprehensive insights about 5+ com...
January 2022
60 pages
Interstitial Lung Disease - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Interstitial Lung Disease - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Intestinal Mucosal Injury - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Intestinal Mucosal Injury - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disea...
January 2022
60 pages
Intestinal Obstruction - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Intestinal Obstruction - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Intracerebral Hemorrhage - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Intracerebral Hemorrhage - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the diseas...
January 2022
60 pages
Intracranial Hemorrhage - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Intracranial Hemorrhage - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease...
January 2022
60 pages
Invasive Aspergillosis- Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Invasive Aspergillosis - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Iron Deficiency Anemia - Pipeline Insight, 2022
US$ 1,500.00
This report can be delivered to the clients within 48 Hours DelveInsight’s, “Iron Deficiency Anemia - Pipeline Insight, 2022” report provides comprehensive insights about 6+ companies and 6+ pipelin...
January 2022
60 pages
Iron Overload Syndrome - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Iron Overload Syndrome - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease,...
January 2022
60 pages
Ischemia reperfusion injury - Epidemiology Forecast - 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Ischemia reperfusion injury - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the dis...
January 2022
60 pages
Ischemic Stroke - Epidemiology Forecast to 2032
US$ 3,950.00
This report can be delivered to the clients within 5-7 Business Days DelveInsight's 'Ischemic Stroke - Epidemiology Forecast to 2032' report delivers an in-depth understanding of the disease, histor...
January 2022
60 pages
